What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Claudia Schoch mainly focuses on Myeloid leukemia, Leukemia, Internal medicine, Cytogenetics and Cancer research.
Claudia Schoch interconnects Myeloid, Molecular biology, BAALC and Bone marrow in the investigation of issues within Myeloid leukemia.
Her Leukemia research incorporates themes from Immunophenotyping and Gene, Chromosomal translocation.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Surgery, Oncology and Pathology.
Her study in Cytogenetics is interdisciplinary in nature, drawing from both Gene chip analysis, Hematology, Gene rearrangement and Bioinformatics.
Her Cancer research study combines topics from a wide range of disciplines, such as Mutation, Fluorescence in situ hybridization and ABL.
Her most cited work include:
- Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. (870 citations)
- Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. (815 citations)
- Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype (618 citations)
What are the main themes of her work throughout her whole career to date?
Myeloid leukemia, Internal medicine, Leukemia, Molecular biology and Oncology are her primary areas of study.
Her Myeloid leukemia study incorporates themes from Myeloid, Karyotype and Cytogenetics.
Her studies deal with areas such as Gastroenterology and Pathology as well as Internal medicine.
Her Leukemia study which covers Gene expression profiling that intersects with DNA microarray, Bioinformatics, Computational biology and Gene chip analysis.
In her study, which falls under the umbrella issue of Molecular biology, Chronic lymphocytic leukemia is strongly linked to Fluorescence in situ hybridization.
The study incorporates disciplines such as Daunorubicin, Survival rate, Surgery and Disease in addition to Oncology.
She most often published in these fields:
- Myeloid leukemia (51.39%)
- Internal medicine (39.24%)
- Leukemia (27.78%)
What were the highlights of her more recent work (between 2005-2013)?
- Myeloid leukemia (51.39%)
- Molecular biology (27.08%)
- Cancer research (24.31%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Myeloid leukemia, Molecular biology, Cancer research, Internal medicine and Genetics.
She does research in Myeloid leukemia, focusing on Imatinib specifically.
Her Molecular biology research incorporates elements of Chromosome, Gene, Karyotype, Chromosomal translocation and Leukemia.
Her work carried out in the field of Leukemia brings together such families of science as Myeloid, Transcription factor, SNP and Mutation.
Her Cancer research research is multidisciplinary, incorporating perspectives in DNA microarray, Microarray analysis techniques and Cytogenetics.
Her Internal medicine research integrates issues from Surgery and Oncology.
Between 2005 and 2013, her most popular works were:
- KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival (321 citations)
- Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease (286 citations)
- The MLL recombinome of acute leukemias. (256 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Her scientific interests lie mostly in Myeloid leukemia, Molecular biology, Cancer research, Genetics and Leukemia.
Her Myeloid leukemia research includes themes of Fluorescence in situ hybridization and Oncology.
She has included themes like Myeloid and SNP in her Molecular biology study.
Her research investigates the connection between Cancer research and topics such as Cytogenetics that intersect with problems in Asparagine and CEBPE.
In general Genetics, her work in Gene, Histone, Acute leukemia and Chromosomal rearrangement is often linked to Methyltransferase linking many areas of study.
As part of the same scientific family, Claudia Schoch usually focuses on Leukemia, concentrating on Chromosomal translocation and intersecting with Core binding factor acute myeloid leukemia and Receptor tyrosine kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
